Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Model structure. ACR20 American College of Rheumatology 20% response ...
ACR20 response criteria in rheumatoid arthritis | Download Scientific ...
Characterization of Clinical Benefits in Subjects Classified As ACR20 ...
Efficacy: a ACR20 response rate; b DAS28-CRP change from the baseline ...
Evaluation of a modified ACR20 scoring system in patients with ...
ACR20 Responses Over Time in Patients Treated with CP-481,715 or ...
ACR20 response rates by visit (ITT population). ACR20/50/70, American ...
Proportions of patients achieving ACR20 response over time through week ...
ACR20 response rates and HAQ-DI scores at week 16 (modified ...
ACR20 response rates at Week 6 (A3921019) and Week 12 (A3921025 ...
PALACE 1-3: ACR20 Response in PsA | Otezla® (apremilast) HCP
MOBILITY: ACR20 co-primary endpoint at week 24. 26 Patients aged 18-75 ...
American College of Rheumatology (ACR) response rates. (A) ACR20 ...
ACR20 response rates at weeks 1, 2, 4, 8, and 12 (FAS). ACR20: American ...
| Differential gene expression and pathway analysis of ACR20 responders ...
Proportions of ACR20 (A), ACR50 (B), and ACR70 (C) responders in the ...
Proportion of ACR20 response treated by DMARDs: (The lighter the color ...
ACR20 and PsARC responder rate at week 12 by concomitant use of DMARDs ...
(a)–(c): The changes in response to treatment, as assessed by ACR20 and ...
Proportion of patients achieving ACR20 response over 52 weeks. ACR20 ...
Time until 25% of patients achieved an ACR20 response (in weeks ...
Patient disposition. a ACR20 response was not achieved at Weeks 12 and ...
Observed ACR20 mean responses() and C-R model predictions for the k in ...
ACR responses over time. ACR20 (NRI-C/NRI) (A), ACR20 (AO) (B), ACR50 ...
Figure S1: ACR20 response rates over time | Download Scientific Diagram
ACR20 and ACR50 responses through 2 years. All data through week 104 ...
Treatment response to week 28. a ACR20 response rates up to week 28. b ...
Proportions of patients who achieved ACR20 over time (a) and DAS28-CRP ...
Independent associated factors to predict ACR20 response after 12 weeks ...
ACR20 response pattern over time. Dots are actual ACR20 response rates ...
Univariate analysis of ACR20 response rate by poor prognostic factors ...
Analysis of ACR20 response rate and infusion-related reaction incidence ...
Percentage of patients achieved ACR20 by week 14 (primary endpoint) for ...
ACR20 response over time (observed). ACR calculated with respect to ...
What Is the ACR20 (American College of Rheumatology) Criteria?
Summary of subgroup analysis for the response of ACR20 in patients with ...
Effect of maximum ADA titer results on ACR20 response rate and mean ...
Deucravacitinib superior to placebo for ACR20 response in psoriatic ...
Proportion of patients achieving composite outcomes: (A) ACR20 ...
Forest plot showing ORs (with 95% CI) of achieving an ACR20 response at ...
ACR20 response rates for different doses of tofacitinib at week 12 and ...
Forest plot showing the efficacy in improving ACR20 score at the end of ...
Deucravacitinib Meets ACR20 Endpoint for Psoriatic Arthritis in Phase 3 ...
New and Upcoming Biologic Agents for Rheumatoid Arthritis
PPT - Evaluating the Use of Actemra ® ( tocilizumab ) for the Treatment ...
New Standards of Care for Rheumatoid Arthritis
Treatment Advances for RA - ppt download
ACR20, ACR50, and ACR70 Responses over a Period of 24 Weeks. Patients ...
Proportions of patients achieving (A) ACR20, (B) ACR50 and (C) ACR70 ...
The proportions of patients achieving an ACR20, ACR50 and ACR70 ...
Psoriatic Arthritis Treatment | RINVOQ® (upadacitinib)
Patients achieving a ACR20, b ACR50, and c ACR70 over 56 weeks ...
ACR20, ACR50, and ACR70 response rates up to week 48 (TP2 per-protocol ...
(A) Proportion of patients with an ACR20, ACR50 or ACR70 response at ...
(A) ACR20/ACR50 response rates through week 156 in all patients ...
ACR20/50/70 response in trials included in meta-analysis | Download Table
ACR20, 50, and 70 responses between treatment groups at weeks 12 and 24 ...
ACR20/50/70 response rates over time. ACR20/ 50/70 indicates American ...
SKYRIZI® Efficacy in Active Psoriatic Arthritis (PsA)
ACR20/50/70 responses with IXE with or without concomitant MTX after ...
ACR20/50/70 response rates at week 24 (TP1 per-protocol set). The ...
Response to ACR20, ACR50 and ACR70 criteria after 1 and 72 months of ...
| The quality assessment of ACR20, ACR50, ACR70, DAS28-ESR, and AEs ...
ACR20, ACR50 and ACR70 responses. a Proportion of patients with an ...
ACR20: Understanding the Key Measure in Rheumatoid Arthritis Clinical ...
| The results of ACR20. | Download Scientific Diagram
SIMPONI ARIA® Psoriatic Arthritis ACR Response Rates | HCP
ACR20, ACR50, and ACR70 at week 12 (per-protocol set). Significant p ...
Joint Efficacy for Psoriatic Arthritis | SKYRIZI® (risankizumab-rzaa)
ACR20, ACR50, and ACR70 response rates at week 28, week 52, and end of ...
ACR20/50/70 a , HAQ-DI b , and PASI50/75 c response rate (SE) by ...
A ACR20/50/70 responses at week 12/ET (FAS). Data shown are the LOCF. A ...
Estimated rates of ACR20/50/70 and EULAR good and good/moderate ...
(A) ACR20, ACR50 and ACR70 response rates at week 12/ET (FAS). (B ...
i ACR20; ii ACR50; iii ACR70 response rates through week 52. Shown are ...
Estimated time–response curves of American College of Rheumatology 20% ...
ACR20, 50 and 70 response rates up to week 54 (full analysis set ...
Biologic Therapy | Psoriatic Arthritis | Healio
Meta-analysis of ACR20, ACR50 and ACR70 responses in up to 24 weeks ...
Patients achieving ACR20/ACR50/ACR70 responses (A) (all patients had ...
Clinical Evidence - SetPoint Medical
ACR Response Criteria in Rheumatoid Arthritis Clinical Trials
ACR20, ACR50 and ACR70 responses after 12 weeks of follow-up in active ...
Proportions of patients achieving a ACR20/50/70 responses, b good EULAR ...
ACR response rates (full-analysis set). a ACR20, b ACR50 and c ACR70 ...
Percentage of patients achieving ACR20/50/70 responses at week 16 (a ...
RINVOQ® (upadacitinib) for Psoriatic Arthritis
Nonbiologic Therapy for Psoriatic Arthritis | Clincical Guidance
Pivotal Clinical Trials
FRI0089 COMPARATIVE EFFICACY (ACR 20) OF TOCILIZUMAB TO OTHER TARGETED ...
SIMPONI ARIA® (golimumab) RA Clinical Trial: ACR Response | HCP
J Clin Rheumatol：类风湿性关节炎患者达到ACR20/50/70的比例-MedSci.cn
Kinase Inhibitors | Rheumatoid Arthritis | Clinical Guidance
Secukinumab for psoriatic arthritis: comparative effectiveness versus ...
